Therapy to treat pelvic floor dysfunction and/or pain

US11213340B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11213340-B2
Application numberUS-201615130344-A
CountryUS
Kind codeB2
Filing dateApr 15, 2016
Priority dateOct 16, 2015
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In some examples, the disclosure describes devices, systems, and techniques for treating pain and/or pelvic floor dysfunction of a patient. For example, a method for treating pelvic floor dysfunction in a patient may include delivering, via a medical device, a therapy to one or more nerve fibers, wherein the therapy is configured to at least temporarily deactivate the one or more nerve fibers; and determining that the one or more nerve fibers was at least temporarily deactivated by delivering the therapy.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical device comprising: an ablation catheter device including: a catheter body; a handle coupled to the catheter body; an electrode disposed on a distal end of the catheter body, the electrode designed to deliver an ablation therapy; and a sensor carried by the catheter body, the sensor designed to sense a patient physiologic parameter, wherein the ablation catheter device is configured to be used to identify one or more target pelvic nerve fibers of a patient based on nerve activity measured by the sensor at the distal end of the catheter body, and wherein the ablation catheter device is configured to communicate with a processor, the processor configured to: cause the ablation therapy to be delivered through the electrode to the one or more target pelvic nerve fibers of the patient to treat pelvic floor dysfunction in the patient, wherein the ablation therapy is configured to at least temporarily deactivate the one or more target nerve fibers, receive from the sensor a sensed patient physiological parameter following delivery of the ablation therapy, and determine whether the sensed patient physiological parameter exceeds a predetermined threshold indicative of the one or more target pelvic nerve fibers being at least temporarily deactivated by delivery of the ablation therapy; wherein the processor is configured to identify the one or more target pelvic nerve fibers based on the nerve activity measured by the sensor at the distal end of the catheter body, wherein the one or more target pelvic nerve fibers is a C fiber that exhibits activation associated with one or more undesirable symptoms or pathological manifestations of the pelvic floor disorder of the patient. 2. The medical device of claim 1 , wherein the ablation therapy delivered through the electrode comprises radio frequency ablation therapy. 3. The medical device of claim 1 , further comprising a second electrode disposed on the distal end of the catheter body to create a bipolar electrode arrangement. 4. The medical device of claim 1 , wherein the patient physiological parameter comprises temperature. 5. The medical device of claim 1 , wherein the patient physiological parameter comprises impedance. 6. The medical device of claim 1 , wherein the patient physiological parameter associated with the pelvic floor dysfunction is selected from the group consisting of: bladder impedance, bladder pressure, bowel impedance, and bowel pressure. 7. The medical device of claim 1 , wherein the patient physiological parameter associated with the pelvic floor dysfunction is selected from the group consisting of: pudendal afferent nerve activity, sacral afferent nerve activity, and muscle activity. 8. The medical device of claim 1 , wherein the patient physiological parameter associated with the pelvic floor dysfunction is motion of the patient. 9. The medical device of claim 1 , wherein the ablation catheter device is configured to communicate with the processor, the processor configured to identify, based on the nerve activity measured by the sensor the distal end of the catheter body, the C fiber by distinguishing the C fiber from other types of nerve fibers or other non-nerve fiber tissue.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11213340B2 cover?
In some examples, the disclosure describes devices, systems, and techniques for treating pain and/or pelvic floor dysfunction of a patient. For example, a method for treating pelvic floor dysfunction in a patient may include delivering, via a medical device, a therapy to one or more nerve fibers, wherein the therapy is configured to at least temporarily deactivate the one or more nerve fibers; …
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1233. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).